Schwabe Pharmaceuticals: Major Study Shows That Long-Term Intake of Ginkgo Biloba Special Extract EGb 761(R) Protects Against Alzheimer’s Disease
KARLSRUHE, Germany--(BUSINESS WIRE)--For the very first time, a medicine has been shown to protect against the development of Alzheimer’s disease. French scientists were able to demonstrate that taking 240 mg of Ginkgo extract EGb 761® per day regularly over a period of at least 4 years can cut the risk of developing Alzheimer’s disease by nearly 50%.